en

PRODUCT DETAIL

ACTAIR 300 IR sublingválne tablety

Code 8174D
MA number 59/0210/21-S
Product Form: tbl slg 30x300 IR (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
V VARIOUS
V01 ALLERGENS
V01A ALLERGENS
V01AA Allergen extracts
V01AA03 House dust mites
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Sublingual use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 13.08.2021
Validity: 13.08.2026
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_ACTAIR 300 IR sublingválne tablety_07_2021.pdf  
SPC: SPC_ACTAIR 300 IR sublingválne tablety_07_2021.pdf  
Safety feature No
Data update: 16.08.2021
eu-flag.png sk-flag.png